The American Heart Association Endorses Oral Device Therapy as an Alternative to CPAP

27 Jul The American Heart Association Endorses Oral Device Therapy as an Alternative to CPAP

Source: News Release from the American Heart Association

 “Recently,  the American Heart Association (AHA) published a scientific statement on OSA and cardiovascular disease.¹ OSA is very prevalent in the U.S., with prevalence being possibly as high as 80% among patients with cardiovascular disease (e.g. stroke, atrial fibrillation, pulmonary hypertension, coronary artery disease, heart failure and hypertension).¹

The AHA’s scientific statement concluded that because continuous positive airway pressure (CPAP) is limited by low patient adherence, alternative therapies are needed. The AHA endorsed oral appliance therapy (OAT) as an effective alternative for treatment of mild-to-moderate OSA and for patients who are unable to tolerate CPAP.¹

OAT is a highly effective therapy for OSA, with ample evidence showing that it not only reduces AHI, but also improves a variety of symptoms and co-morbidities ranging from excessive daytime sleepiness and cognition to high blood pressure and cardiovascular mortality.”

References:

1. Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, Mehra R, Bozkurt B, Ndumele CE, Somers VK; on behalf of the American Heart Association Council on Clinical Cardiology; Council on Peripheral Vascular Dis-ease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Stroke Council; and Council on Cardiovascular Surgery and Anesthesia. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Asso-ciation. Circulation. 2021;143:e•••–e•••. doi: 10.1161/CIR.0000000000000988